NEWRON PHARMA N/ IT0004147952 /
2024-04-23 5:30:49 PM | Chg. -0.180 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.000CHF | -2.51% | 32,096 Turnover: 223,924.530 |
6.890Bid Size: 1,000 | 7.290Ask Size: 1,499 | 124.92 mill.CHF | - | - |
GlobeNewswire
7:28 PM
VTYX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Sec...
GlobeNewswire
7:26 PM
KIND, KVSB DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Nextdoor Holdings, Inc. f/k/a Khosla Vent...
GlobeNewswire
7:26 PM
NetLogistik Named to Inbound Logistics Top 100 Logistics IT Providers Award 2024
GlobeNewswire
7:07 PM
ZEN IN THE CITY: PENTHOUSE AT I.M. PEI & PEI PARTNERSHIP ARCHITECTS CONDO MARRIES EAST AND WEST
GlobeNewswire
7:00 PM
Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa...
GlobeNewswire
6:55 PM
SNOW DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Snowflake Inc. Investors to Secure Counse...
GlobeNewswire
6:30 PM
Axalta Irus Mix and Voltatex® 7345 A ECO Wire Enamel Win Silver 2024 Edison Awards™; Low Carbon Foot...
GlobeNewswire
6:30 PM
Maryland CareerQuest Connects Area Students with Training and Education Opportunities for Hands-On C...
GlobeNewswire
6:30 PM
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Plug Power Inc. with Losses o...
GlobeNewswire
6:17 PM
DigiKey to Showcase Full Automation Offerings and Value-Add Services at Automate 2024